Patents Assigned to Celvia CC AS
  • Endometrial receptivity determination
    Patent number: 12625145
    Abstract: Endometrial receptivity status is determined by measuring, in an uterine fluid sample taken from a woman, the amounts of at least three proteins selected among NNMT, LCN2, PGR, SLC26A2, SLC34A2, TCN1, ENPP3, GRN, STC1, DPP4, MPO, CD55, ELANE, MSLN, CTSB, RNASET2, CRISP3, MVP, MMP26, AOC1 and SDCBP2. The EM receptivity status of the woman is determined based on a comparison of the measured amounts of the at least three proteins with respective control amounts.
    Type: Grant
    Filed: May 11, 2020
    Date of Patent: May 12, 2026
    Assignee: Celvia CC AS
    Inventors: Andres Salumets, Sergo Kasvandik, Maire Peters, Tanel Kaart